Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Other Working Capital Changes (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Other Working Capital Changes for 16 consecutive years, with $33000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes fell 2.94% to $33000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$599000.0, a 270.17% decrease, with the full-year FY2024 number at $218000.0, up 199.09% from a year prior.
  • Other Working Capital Changes was $33000.0 for Q3 2025 at Xtant Medical Holdings, up from -$67000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $376000.0 in Q1 2024 to a low of -$543000.0 in Q2 2022.
  • A 5-year average of -$26842.1 and a median of $33000.0 in 2025 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: crashed 586.36% in 2023, then soared 452.94% in 2024.
  • Xtant Medical Holdings' Other Working Capital Changes stood at -$59000.0 in 2021, then soared by 62.71% to -$22000.0 in 2022, then plummeted by 586.36% to -$151000.0 in 2023, then crashed by 88.74% to -$285000.0 in 2024, then skyrocketed by 111.58% to $33000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Other Working Capital Changes are $33000.0 (Q3 2025), -$67000.0 (Q2 2025), and -$280000.0 (Q1 2025).